Indian regulator gets WHO nod; EU to review Sanofi quadrivalent vax;

> The Indian regulatory system has passed a WHO assessment, meaning its vaccine manufacturers keep prequalification status. Article

> GE Healthcare and iBio have allied to build a green plant-based vaccine production facility in Brazil. Item

> Research shared at the American Association for Cancer Research (AACR) meeting shows women with HIV are commonly infected with HPV strains not covered by current vaccines. Release

> RTP-based service provider Scynexis has teamed up with Immune Design Corp to develop an adjuvant. Piece

> European regulators have agreed to review an application Sanofi's ($SNY) quadrivalent flu vaccine. Item

Suggested Articles

CEPI, which started to help prepare the world for new outbreaks, has awarded Inovio and Moderna money for vaccine work against the new coronavirus.

As a new coronavirus spreads, vaccine researchers have started work on candidates against the virus—and one could enter the clinic in a few months.

Merck's HPV vaccine Gardasil is delivering blockbuster sales as demand surges. But high demand has caused somewhat of a supply constraint.